RS

Dementia

Serious loss of global cognitive ability

  • Not normal age-related cognitive declines

  • Impaired memory and cognitive function

  • MMSE (mini mental status exam) to assess cognitive abilities

A syndrome (group of symptoms), not a specific disorder

Usually progressive- neurodegenerative

Not progressive usually if caused by… TBI or stoke, drug use

Mild Cognitive Impairment (MCI)

  • MMSE score 20-26

  • Cognitive deficient, but doesn’t interfere with daily living

  • Sometimes a precursor to Alzheimer’s disease

Alzheimer’s Disease (AD)

  • 80% of all dementias

  • Slow progression

  • Usually normal motor control

  • Mild depression and some social withdrawal

  • Early stage- lasts 2-4 years

    • Frequent memory loss of recent memories, but older memories preserved

    • Place objects in odd places

  • Second stage- lasts 2-10 years

    • More pervasive memory loss, involving older memories

    • Nonsensical speech

    • Easily get lost

    • Lose inhibitions (say/ do inappropriate things)

  • Late stage- lasts 1-3 years

    • Confused, unable to carry out conversations

    • Major mobility difficulties

    • Difficulty swallowing

Frontotemporal Dementia

  • Most common dementia in people under 65 years old

  • Executive Function

  • Apathy and social withdrawal are common

  • Lack of inhibition

    • Theft, erratic driving, disinhibited sexual desire

  • Compulsive behaviors such as overreacting

  • Loss of speech fluency, but no change in language comprehension

Vascular Dementia

  • Less memory loss and more loss of cognitive speed and problem solving

  • Difficulty with organization

  • Difficulty deciding what to do next

  • Difficulty in making a plan

  • Difficulty following a series of steps (cooking)

  • Showed speed of thought

  • Problems concentrating

Lewy Body Dementia

  • 2nd most common type of dementia

  • Confusion, poor attention, visual-spatial problems, memory loss

  • Fluctuating cognition

  • Early Stage

    • Visual hallucinations

    • Movement disorders that look like parkinsons disease

      • Slowed movement, rigid muscles, tremor, shuffling walks

  • Middle Stage

    • REM sleep disorders

  • Poor regulation of blood pressure, heart rate, sweating, digestion

Chapter 4 Reading

Alzheimer’s Disease Anatomical Changes

  • Shrinkage of cortex

  • Shrinkage starts in cortex near hippocampus (memory) & spreads

  • Ventricles (hollow pockets in brain that hold CSF) get bigger because brain is getting smaller

  • Tangles of neurofibrillary tangles and amyloid plagues

    Frontotemporal Dementia

    • Shrinkage of frontal lobe not of cortex

AD: Amyloid Plaques and Neurofibrillary Tangles

Tau: Holds together microtubules

  • During Alzheimers, tau becomes hyperphosphorylated in AD and doesn’t dissolve anymore, no longer binds microtubules together

  • These tangles are killing neurons in AD

Tangles

  • APP Amyloid precursor protein, sits in cell membranes (don’t know what they do)

Prion= Protein in cell membranes that can become misfolded, and if it interacts with a normal prion it causes them to misfold (mad cow disease)

How does AD Pathology spread across the brain?

  • Starts in medial temporal lobe spread to surrounding cortex

  • Beta amyloid (AB) plaque formation may spread like prions

    • Misfolded AB might serve as template for misfolding

    • AD as a communicable disease (don’t eat human brains)

Genetics of Alzheimer’s Disease

  • 1% of AD cases are inherited autosomal dominant disease

  • 99% show genetic predisposition

    • Heritability = 0.6 - 0.8

  • APOE

    • Lipid binding protein synthesized in liver, glial cells, and neurons

    • Neurons have receptors for APOE

    • e4 allele (14% of pop) increases AD risk up to 15x

    • e2 allele (7% of pop) reduces AD risk

    • e3 allele (79% of pop) is neutral

  • Many other genes that have much smaller effects

Verret el al Paper

  • Parvalbumin-positive (PV) inhibitory interneurons, which are essential for regulating neural network activity and cognitive functions.

  • Restoring the function of inhibitory interneurons is suggested as a possible therapeutic approach